Stratification of ALS patients' survival: a population-based study. (Q39215197)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518423%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Stratification of ALS patients' survival: a population-based study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518423%20AND%20SRC:MED&resulttype=core&format=json

amyotrophic lateral sclerosis

28 February 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518423%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Simona Arcuti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518423%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Massimiliano Copetti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518423%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Andrea Fontana

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518423%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Pierre-Marie Preux

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518423%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Philippe Couratier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518423%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Marie Nicol

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518423%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Marie Raymondeau

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518423%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Giancarlo Logroscino

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518423%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

30 October 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518423%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518423%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518423%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518423%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

100-111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518423%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-015-7940-z

28 February 2020

exact match

0 references

cites work

Amyotrophic Lateral Sclerosis: An Aging-Related Disease

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

The epidemiology of ALS and the role of population-based registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe--the French register of ALS in Limousin (FRALim register).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Prognostic factors in ALS: A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Long-term survival in amyotrophic lateral sclerosis: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Clinical epidemiology of ALS in Liguria, Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Amyotrophic lateral sclerosis in Catalonia: a population based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Factors Predicting Survival in ALS Patients--Data from a Population-Based Registry in Rhineland-Palatinate, Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Prognosis in amyotrophic lateral sclerosis: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Amyotrophic lateral sclerosis. A study of its presentation and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Epidemiology of amyotrophic lateral sclerosis in Isfahan, Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Survival of patients with amyotrophic lateral sclerosis in 2 Danish counties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Onset, natural history and outcome in idiopathic adult motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Effects of demographic factors on survival time after a diagnosis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Japanese and American ALS patient preferences regarding TIV (tracheostomy with invasive ventilation): a cross-national survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Prognosis of ALS: comparing data from the Limousin referral centre, France, and a Uruguayan population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Effect of referral bias on assessing survival in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Prognosis of amyotrophic lateral sclerosis and the effect of referral selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Linear estimates of rates of disease progression as predictors of survival in patients with ALS entering clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Capture-recapture methods in epidemiology: methods and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

The natural history of benign thyroid nodules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Treatment optimization and prediction of HCV clearance in patients with acute HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Assessing the performance of prediction models: a framework for traditional and novel measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Survival and clinical features in Hispanic amyotrophic lateral sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7940-Z

Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995-2009

21 January 2018

1 reference

12 December 2020

Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy

1 reference

12 December 2020

Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): A population based study

1 reference

12 December 2020

A score including ADAM17 substrates correlates to recurring cardiovascular event in subjects with atherosclerosis

1 reference

12 December 2020

Epidemiological and clinical patterns of western pacific amyotrophic lateral sclerosis (ALS) in Guam and sporadic ALS in Rochester, Minnesota, U.S.A. and Hokkaido, Japan: a comparative study

1 reference

12 December 2020

Predictors of long survival in amyotrophic lateral sclerosis: A population-based study

1 reference

12 December 2020

Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

1 reference

12 December 2020

Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?

1 reference

12 December 2020

The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group

1 reference

12 December 2020

ALS clinical trials: Do enrolled patients accurately represent the ALS population?

1 reference

12 December 2020

Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study

1 reference

12 December 2020

10.1007/S00415-015-7940-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518423%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference